COVID Genomic Research Contract

COVID Genomic Research Contract

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection.

United Kingdom-London: Supply services of nursing personnel

2020/S 158-386854

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Genomics England Limited
Postal address: Dawson Hall, Charterhouse Square
Town: London
NUTS code: UK UNITED KINGDOM
Postal code: EC1M 6BQ
Country: United Kingdom
E-mail: paul.nicholson@genomicsengland.co.uk
Telephone: +44 2078825030
Internet address(es):Main address: www.genomicsengland.co.uk

I.2)Information about joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://genomicsengland.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://genomicsengland.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

COVID Related Sample Collection Service

Reference number: GeL-COV-159-20

II.1.2)Main CPV code

79624000 Supply services of nursing personnel

II.1.3)Type of contract

Services

II.1.4)Short description:

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered COVID symptoms to provide a control cohort in support of COVID genomic research. This Contract Notice aim is to select a provider for at least 10,000 mild samples and additional severe samples and other co-recruitment samples. Numbers of these severe samples and co-recruitment samples are not currently known with requirements being developed through 2020.

II.1.5)Estimated total value

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:

II.2.2)Additional CPV code(s)

79624000 Supply services of nursing personnel
79625000 Supply services of medical personnel

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM
Main site or place of performance:

Nationwide

II.2.4)Description of the procurement:

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection. The study aims to understand the genetic factors that influence risk of severe COVID-19. It has been designated as an urgent public health study by the NIHR and is jointly funded by the Department of Health and Social Care, UKRI and NIHR.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered mild or asymptomatic COVID symptoms to provide a control cohort in support of COVID genomic research. GEL does not have integral sample collection capability, and support from NIHR research nurses and NHS Trusts to collect samples is not guaranteed, nor are they able to support home visits, the preferred collection method. This Contract Notice is to select a provider for the remaining 10,000+ samples to work with GEL from around October 2020 onwards.

Severe Retrospective Cases. Current severe retrospective recruitment numbers indicate that up to 70 % of volunteers will request a home visit for their sample collection. As a result, the samples that the collection provider will be required to collect will include both mild, and severe retrospective. The numbers of severe cases will be over and above the 10,000 mild samples but are not currently determined.

Additional Co-recruitment – (not yet confirmed). There is the possibility that the collection provider will also be asked to perform additional sample collection in certain instances. This would result in a 6-8 week period during which the majority, if not all, cases up to a volume of approximately 10,000 would require blood collection that includes the standard collection for the mild samples and other collection services during the same appointment.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 12
This contract is subject to renewal: yes
Description of renewals:

12 month extension option

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 28/08/2020
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 30/10/2020

IV.2.7)Conditions for opening of tenders

Date: 28/08/2020
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic invoicing will be accepted
Electronic payment will be used

VI.3)Additional information:

NB: The services required have been deemed to fall under the list of Services covered by the Light-Touch Regime under Schedule 3 of the Public Contracts Regulations 2015 and as such the procurement procedure reflects the necessary timescales required to meet the project requirements.

The procurement procedure meets the requirements of a light touch regime procurement and is reasonable in terms of approach and timings. Mandatory and discretionary exclusions apply and will be assessed as pass/fail requirements as part of tenderer’ submissions following the exclusions set out within the standard selection questionnaire. Evaluation will be conducted against set criteria and decisions based on best price quality ratio (BPQR) to determine the successful service provider.

VI.4)Procedures for review

VI.4.1)Review body

Official name: High Court
Town: London
Country: United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

10/08/2020